Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multi-centre, single-arm, phase 2 study (vol 16, pg 57, 2015)

Topp M. S.; Gockbuget N.; Stein A. S.

首页> 外文期刊>The lancet oncology >Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multi-centre, single-arm, phase 2 study (vol 16, pg 57, 2015)

【24h】

Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multi-centre, single-arm, phase 2 study (vol 16, pg 57, 2015)

机译：Blinatumomab对成年复发或难治性B前体急性淋巴细胞白血病成人患者的安全性和活性：一项多中心，单组，2期研究（第16卷，第57页，2015年）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The lancet oncology》 |2015年第4期|共1页
作者
Topp M. S.; Gockbuget N.; Stein A. S.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multi-centre, single-arm, phase 2 study (vol 16, pg 57, 2015) [J] . Topp M. S., Gockbuget N., Stein A. S. The lancet oncology . 2015,第4期

机译：Blinatumomab对成年复发或难治性B前体急性淋巴细胞白血病成人患者的安全性和活性：一项多中心，单组，2期研究（第16卷，第57页，2015年）
2. Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter Study (vol 35, pg 1795, 2017) [J] . Martinelli Journal of Clinical Oncology . 2017,第24期

机译：成人患者的完全血液学和分子反应复发/难治性费城染色体阳性B-前体急性淋巴细胞白血病，后伴有BLINATUMOMAB治疗：II期，单臂，多中心研究（Vol 35，PG 1795,2017）的结果
3. Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter Study [J] . Martinelli Giovanni, Boissel Nicolas, Chevallier Patrice, Journal of Clinical Oncology . 2017,第16期

机译：成年患者的完全血液学和分子反应患者复发/难治性费城染色体阳性B-前体急性淋巴细胞白血病，后伴有BLINATUMOMAB处理：II期，单臂，多中心研究的结果
4. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
5. Blinatumomab retreatment after relapse in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia [O] . M S Topp, M Stelljes, G Zugmaier, -1

机译：复发/难治性B前体急性淋巴细胞白血病患者复发后的Blinatumomab复治
6. Complete hematologic and molecular response in adult patients with relapsed/refractory philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia following treatment with blinatumomab: results from a phase II, single-arm, multicenter study [O] . Martinelli Giovanni, Boissel Nicolas, Chevallier Patrice, 2017

机译：成年复发/难治性费城染色体阳性B前体急性淋巴细胞白血病患者接受blinatumomab治疗后的完整血液学和分子反应：II期，单臂，多中心研究的结果

Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multi-centre, single-arm, phase 2 study (vol 16, pg 57, 2015)

著录项

相似文献

相关主题

期刊订阅